Evidence map›Paper›PMID 41044099›Full record

ArticleScientific reports2025

Sociodemographic determinants and temporal variability of blood lead levels (2003-2019) in a pooled analysis of nine studies in four European countries.

Elena Salamanca-Fernández, Francisco M Peinado, Marta Esteban-López, Vladimira Puklova, Rafael M Poyatos, Eva Govarts, Michelle Laeremans, Martine Leermakers, Elly den Hond, Greet Schoeters and 11 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Elena Salamanca-Fernández *Biomedical Research Center (CIBM), Department of Radiology and Physical Medicine, Medical School, University of Granada, Granada, Spain.
Francisco M Peinado *Biomedical Research Center (CIBM), Department of Radiology and Physical Medicine, Medical School, University of Granada, Granada, Spain.
Marta Esteban-LópezEnvironmental Toxicology Unit, National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain.
Vladimira PuklovaCentre for Health and Environment, National Institute of Public Health, Prague, Czech Republic.
Rafael M PoyatosUnidad de Gestión Clínica de Laboratorios, Hospital Universitario San Cecilio, Granada, Spain.
Eva GovartsVITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium.
Michelle LaeremansVITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium.
Martine LeermakersAnalytical, Environmental and Geo-Chemistry Department (AMGC), Vrije Universiteit Brussel, Brussels, Belgium.
Elly den HondVITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium.
Greet SchoetersDepartment of Biomedical Sciences, University of Antwerp, Antwerp, 2610, Belgium.
Aline MurawskiGerman Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany.
Susana Pedraza-DíazEnvironmental Toxicology Unit, National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain.
Tamás SzigetiNational Center for Public Health and Pharmacy, Albert Flórián út 2-6, Budapest, 1097, Hungary.
Veerle VerheyenVITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium.
Nina VogelGerman Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany.
Till WeberGerman Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany.
Domenica HahnGerman Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany.
Philipp ZimmermannGerman Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany.
Marike Kolossa-GehringGerman Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany.
Mariana F FernandezBiomedical Research Center (CIBM), Department of Radiology and Physical Medicine, Medical School, University of Granada, Granada, Spain. marieta@ugr.es.
Juan Pedro ArrebolaInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain.

Funding

European Union's Horizon 2020 research and innovation program HBM4EU, No. 733032
6 · The paper itself

Abstract

Despite regulatory actions, lead (Pb) exposure remains a major environmental health concern worldwide due to its widespread occurrence and potential adverse effects. The aims of this study were to explore internal Pb exposure in EU citizens, identify its main sociodemographic determinants, and investigate temporal variations over the last decades. Blood Pb data from a total of 17,790 individuals from 9 biomonitoring studies conducted between 2003 and 2019 in four European countries [Belgium (FLEHS I-IV), teenagers and adults; Czech Republic (SZU), children and adults; Spain (BIOAMBIENT.ES), adults; Germany (ESB, GerES IV and V), with all three age groups] were used. The European Human Biomonitoring Initiative (HBM4EU) harmonized and integrated the different datasets. Linear mixed-model analyses were performed to explore exposure determinants related to Pb concentrations. All participants showed detectable blood Pb concentrations, with an overall mean concentration (± standard deviation) of 20.6 (± 16.7) µg/L. In multivariable analyses, older age at recruitment, smoking habit and residence in more urbanized areas were associated with higher Pb levels, whereas more recent sampling year and higher educational level with lower concentrations. After pooled analysis of individual data, no significant differences were found in the Pb levels of the European citizens studied, probably due to the heterogeneity of the studies included. Collaborative efforts between public health agencies, environmental regulators and communities must continue to monitor trends, explore emerging sources of exposure and refine strategies to ensure sustained progress in reducing Pb levels and protecting the health of European population.

Indexed as

Environmental ExposureLeadAdolescentAdultAgedBiological MonitoringChildEuropeFemaleHumansMaleMiddle AgedSociodemographic FactorsYoung AdultLeadBloodEuropeHBM4EUHuman biomonitoringLeadRegulation policies

Identifiers

PMID41044099
PMCPMC12494996

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.